261 related articles for article (PubMed ID: 26595093)
1. Leishmania vaccine development: exploiting the host-vector-parasite interface.
Reed SG; Coler RN; Mondal D; Kamhawi S; Valenzuela JG
Expert Rev Vaccines; 2016; 15(1):81-90. PubMed ID: 26595093
[TBL] [Abstract][Full Text] [Related]
2. Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model.
Gomes R; Teixeira C; Teixeira MJ; Oliveira F; Menezes MJ; Silva C; de Oliveira CI; Miranda JC; Elnaiem DE; Kamhawi S; Valenzuela JG; Brodskyn CI
Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7845-50. PubMed ID: 18509051
[TBL] [Abstract][Full Text] [Related]
3. Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease.
Oliveira F; Lawyer PG; Kamhawi S; Valenzuela JG
PLoS Negl Trop Dis; 2008 Apr; 2(4):e226. PubMed ID: 18414648
[TBL] [Abstract][Full Text] [Related]
4. Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.
Zahedifard F; Gholami E; Taheri T; Taslimi Y; Doustdari F; Seyed N; Torkashvand F; Meneses C; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2751. PubMed ID: 24675711
[TBL] [Abstract][Full Text] [Related]
5. Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania.
Collin N; Gomes R; Teixeira C; Cheng L; Laughinghouse A; Ward JM; Elnaiem DE; Fischer L; Valenzuela JG; Kamhawi S
PLoS Pathog; 2009 May; 5(5):e1000441. PubMed ID: 19461875
[TBL] [Abstract][Full Text] [Related]
6. A Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major.
Abi Abdallah DS; Pavinski Bitar A; Oliveira F; Meneses C; Park JJ; Mendez S; Kamhawi S; Valenzuela JG; Marquis H
Infect Immun; 2014 Jul; 82(7):2736-45. PubMed ID: 24733091
[TBL] [Abstract][Full Text] [Related]
7. Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection.
Gomes R; Oliveira F; Teixeira C; Meneses C; Gilmore DC; Elnaiem DE; Kamhawi S; Valenzuela JG
J Invest Dermatol; 2012 Dec; 132(12):2735-43. PubMed ID: 22739793
[TBL] [Abstract][Full Text] [Related]
8. LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.
Aguiar-Soares RD; Roatt BM; Ker HG; Moreira Nd; Mathias FA; Cardoso JM; Gontijo NF; Bruna-Romero O; Teixeira-Carvalho A; Martins-Filho OA; Corrêa-Oliveira R; Giunchetti RC; Reis AB
Parasit Vectors; 2014 Feb; 7():61. PubMed ID: 24507702
[TBL] [Abstract][Full Text] [Related]
9. A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.
Oliveira F; Rowton E; Aslan H; Gomes R; Castrovinci PA; Alvarenga PH; Abdeladhim M; Teixeira C; Meneses C; Kleeman LT; Guimarães-Costa AB; Rowland TE; Gilmore D; Doumbia S; Reed SG; Lawyer PG; Andersen JF; Kamhawi S; Valenzuela JG
Sci Transl Med; 2015 Jun; 7(290):290ra90. PubMed ID: 26041707
[TBL] [Abstract][Full Text] [Related]
10. Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters.
Fiuza JA; Dey R; Davenport D; Abdeladhim M; Meneses C; Oliveira F; Kamhawi S; Valenzuela JG; Gannavaram S; Nakhasi HL
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004322. PubMed ID: 26752686
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.
Cecílio P; Pérez-Cabezas B; Fernández L; Moreno J; Carrillo E; Requena JM; Fichera E; Reed SG; Coler RN; Kamhawi S; Oliveira F; Valenzuela JG; Gradoni L; Glueck R; Gupta G; Cordeiro-da-Silva A
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005951. PubMed ID: 29176865
[TBL] [Abstract][Full Text] [Related]
12. Immunization of Experimental Dogs With Salivary Proteins From
Abbehusen MMC; Cunha J; Suarez MS; Teixeira C; Almeida VDA; Pereira LDS; Bordoni M; Gil-Santana L; Solcà MDS; Fraga DBM; Fischer L; Bozza PT; Veras PST; Valenzuela JG; Kamhawi S; Andrade BB; Brodskyn CI
Front Immunol; 2018; 9():2558. PubMed ID: 30519235
[TBL] [Abstract][Full Text] [Related]
13. Identifying vaccine targets for anti-leishmanial vaccine development.
Sundar S; Singh B
Expert Rev Vaccines; 2014 Apr; 13(4):489-505. PubMed ID: 24606556
[TBL] [Abstract][Full Text] [Related]
14. Comparative Evolution of Sand Fly Salivary Protein Families and Implications for Biomarkers of Vector Exposure and Salivary Vaccine Candidates.
Coutinho-Abreu IV; Valenzuela JG
Front Cell Infect Microbiol; 2018; 8():290. PubMed ID: 30211125
[TBL] [Abstract][Full Text] [Related]
15. Vector saliva in vaccines for visceral leishmaniasis: a brief encounter of high consequence?
Kamhawi S; Aslan H; Valenzuela JG
Front Public Health; 2014; 2():99. PubMed ID: 25152872
[TBL] [Abstract][Full Text] [Related]
16. Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle.
Cecílio P; Oristian J; Meneses C; Serafim TD; Valenzuela JG; Cordeiro da Silva A; Oliveira F
Sci Rep; 2020 Oct; 10(1):18653. PubMed ID: 33122717
[TBL] [Abstract][Full Text] [Related]
17. Status of vaccine research and development of vaccines for leishmaniasis.
Gillespie PM; Beaumier CM; Strych U; Hayward T; Hotez PJ; Bottazzi ME
Vaccine; 2016 Jun; 34(26):2992-2995. PubMed ID: 26973063
[TBL] [Abstract][Full Text] [Related]
18. Vaccinomics strategy to concoct a promising subunit vaccine for visceral leishmaniasis targeting sandfly and leishmania antigens.
Ojha R; Pandey RK; Prajapati VK
Int J Biol Macromol; 2020 Aug; 156():548-557. PubMed ID: 32311400
[TBL] [Abstract][Full Text] [Related]
19. Vector transmission of leishmania abrogates vaccine-induced protective immunity.
Peters NC; Kimblin N; Secundino N; Kamhawi S; Lawyer P; Sacks DL
PLoS Pathog; 2009 Jun; 5(6):e1000484. PubMed ID: 19543375
[TBL] [Abstract][Full Text] [Related]
20. Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against
Seyed N; Peters NC; Rafati S
Front Immunol; 2018; 9():1227. PubMed ID: 29922288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
